HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Syd Johnson Selected Research
Syd Johnson Research Topics
Disease
19
Infections
01/2019 - 05/2005
8
Neoplasms (Cancer)
01/2018 - 09/2007
6
West Nile Fever
12/2011 - 05/2005
3
Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 05/2015
3
B-Cell Lymphoma (Lymphoma, B Cell)
01/2018 - 10/2006
3
Flavivirus Infections
11/2011 - 12/2007
3
Severe Dengue
02/2010 - 12/2007
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016 - 05/2015
2
Thrombocytopenia (Thrombopenia)
09/2015 - 02/2010
2
Body Weight (Weight, Body)
04/2015 - 06/2010
2
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2013 - 08/2011
2
Dengue (Dengue Fever)
02/2013 - 02/2010
2
Autoimmune Diseases (Autoimmune Disease)
01/2012 - 09/2007
2
Hypersensitivity (Allergy)
01/2012 - 07/2007
2
Virus Diseases (Viral Diseases)
09/2010 - 12/2007
1
Colorectal Neoplasms (Colorectal Cancer)
01/2018
1
Colonic Neoplasms (Colon Cancer)
01/2018
1
Lymphoma (Lymphomas)
01/2018
1
Leukemia
01/2018
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1
Cytokine Release Syndrome
09/2015
1
Arthritis (Polyarthritis)
08/2014
1
Exanthema (Rash)
08/2011
1
Anthrax
06/2011
1
Edema (Dropsy)
06/2011
1
Breast Neoplasms (Breast Cancer)
01/2011
1
Burkitt Lymphoma (Burkitt's Lymphoma)
06/2010
1
Viremia
02/2010
1
Emerging Communicable Diseases (Emerging Infectious Diseases)
02/2010
1
Paralysis (Palsy)
04/2008
1
acute flaccid myelitis
04/2008
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2007
1
Respiratory Syncytial Virus Infections
05/2007
1
Encephalitis (Encephalitis, Rasmussen)
11/2006
Drug/Important Bio-Agent (IBA)
20
Monoclonal Antibodies
IBA
01/2019 - 05/2005
12
Antibodies
IBA
01/2016 - 05/2005
6
Proteins (Proteins, Gene)
FDA Link
01/2018 - 11/2006
5
Antigens
IBA
01/2018 - 06/2010
4
Bispecific Antibodies
IBA
01/2018 - 06/2010
3
Vaccines
IBA
02/2013 - 09/2010
3
Epitopes
IBA
12/2011 - 05/2005
3
Immunoglobulin G (IgG)
IBA
11/2009 - 12/2007
2
Cytokines
IBA
01/2018 - 02/2010
2
Glycoproteins (Glycoprotein)
IBA
01/2018 - 09/2005
2
teplizumab
IBA
11/2013 - 08/2011
2
Complement System Proteins (Complement)
IBA
11/2011 - 12/2007
1
Perforin
IBA
01/2018
1
Granzymes (Granzyme)
IBA
01/2018
1
PF-06671008
IBA
03/2016
1
Cadherins (E-Cadherin)
IBA
03/2016
1
Interleukins
IBA
01/2016
1
Interleukin-3 Receptor alpha Subunit
IBA
01/2016
1
Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)
IBA
09/2015
1
Explosive Agents (Explosives)
IBA
08/2014
1
C-Peptide
IBA
11/2013
1
Antiviral Agents (Antivirals)
IBA
02/2013
1
Blocking Antibodies
IBA
02/2013
1
Surface Antigens (Surface Antigen)
IBA
07/2012
1
Platelet Activating Factor
IBA
01/2012
1
GMA-161
IBA
01/2012
1
Opsonin Proteins (Opsonins)
IBA
11/2011
1
Fc Receptors (Fc Receptor)
IBA
08/2011
1
Insulin (Novolin)
FDA Link
08/2011
1
T-Cell Antigen Receptor-CD3 Complex
IBA
04/2011
1
CD19 Antigens
IBA
04/2011
1
Trastuzumab (Herceptin)
FDA Link
01/2011
1
Immunoglobulin Fragments
IBA
06/2010
1
Neutralizing Antibodies
IBA
04/2010
1
IgG Receptors (Fc gamma RI)
IBA
10/2009
1
motavizumab (Numax)
IBA
05/2007
1
Fc gamma receptor IIB
IBA
10/2006
Therapy/Procedure
12
Therapeutics
09/2015 - 10/2006
3
Immunotherapy
01/2018 - 09/2007
1
Treatment Delay
06/2011
1
Intravenous Infusions
06/2010